Howe & Rusling Inc Invitae Corp Transaction History

Howe & Rusling Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.13 - $9.01 $213 - $901	-100 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$6.28 - $15.59 $628 - $1,559	100 New	100 $1,000
Q1 2020 May 14, 2020	SELL	$7.64 - $27.5 $458 - $1,650	-60 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$15.02 - $20.57 $901 - $1,234	60 New	60 $1,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.